Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
2-((6S,12R,17R,20S,23S,25aS,31S,34S,37S,40S,43R,46S,48aS,53R)-6-((1H-imidazol-5-yl)methyl)-31,34-bis(2-amino-2-oxoethyl)-53-(2-aminoacetamido)-9-(aminomethyl)-20-((S)-sec-butyl)-17-carbamoyl-40-(hydroxymethyl)-37-isopropyl-46-methyl-5,8,11,19,22,25,30,33,36,39,42,45,48,54-tetradecaoxohexatetracontahydro-12,43-(epiminopropanodithiomethano)dipyrrolo[2,1-h<sub>1</sub>:2',1'-m][1,2,5,8,11,14,17,20,23,26,29,32,35,38,41]dithiatridecaazacyclotetratetracontin-23-yl)acetic acid
ID: ALA5203781
PubChem CID: 168293547
Max Phase: Preclinical
Molecular Formula: C62H96N22O21S4
Molecular Weight: 1613.85
Associated Items: